We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Clinical Chemistry

Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

A new urine test tracks enzyme activity to support earlier, ongoing monitoring of lung cancer and pulmonary fibrosis. More...
15 May 2026
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

A new test measures pTau217 to rule in or rule out amyloid pathology, enabling earlier, less invasive Alzheimer’s assessment. More...
14 May 2026
Image: Processed on IDS’ random-access automation platforms, the comprehensive portfolio enables direct ChLIA measurement of total testosterone, SHBG, and free testosterone (photo courtesy of Revvity)

FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing

Revvity receives FDA clearance for total testosterone assay enabling comprehensive automated testing. More...
13 May 2026
Image: The addition of pTau 217 complements blood-based approaches for clinical decision-making in neurology workflows. The fully automated format supports scalability on the LUMIPULSE G platform (photo courtesty of Shutterstock)

CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics

Fujirebio announced CE marking for the Lumipulse G pTau 217 Plasma assay, a fully automated test that quantitatively measures pTau 217 in human plasma. More...
13 May 2026
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

New data identify urinary metabolite signatures that may enable earlier, noninvasive identification of bipolar, ADHD and anorexia. More...
12 May 2026
Image: The at-home approach combines a finger-prick capillary blood test, returned to a laboratory by mail, with online cognitive assessments completed from home (image credit: 123RF)

At-Home Blood and Cognitive Tests Support Dementia Risk Stratification

A new at-home finger-prick blood test paired with online cognitive checks enables remote stratification of dementia risk. More...
12 May 2026
Image: The dSAA method partitions a patient’s cerebrospinal fluid into nanoliter-scale compartments and digitally counts the number of TDP-43 protein “seeds” present under a microscope (image credit: Shutterstock)

Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype

An ultrasensitive CSF assay enables noninvasive FTLD-TDP identification and severity monitoring More...
06 May 2026
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Repetitive Pipette
VWR® Stepper Pro


The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.
Copyright © 2000-2026 Globetech Media. All rights reserved.